PET imaging of cellular proliferation
作者： David A. Mankoff , Anthony F. Shields , Kenneth A. Krohn
DOI: 10.1016/J.RCL.2004.09.005
关键词: Positron emission tomography 、 Thymidine 、 In vivo 、 Cancer 、 In vitro 、 Clinical trial 、 Cytotoxic T cell 、 Cancer research 、 Pathology 、 Stage (cooking) 、 Medicine
摘要: … decrease in cellular proliferation is one of the earliest events in response to successful treatment. This was the basis of predictive assays using cultured cells and proliferation response …
elsevier.com
sci-hub.se 参考文章(79)
Jeffrey T. Yap, Vincent J. Cunningham, Pat Price, Roger N. Gunn, Paula Wells, Safiye Osman, Terry Jones, A General Method to Correct PET Data for Tissue Metabolites Using a Dual-Scan Approach The Journal of Nuclear Medicine. ,vol. 41, pp. 706- 711 ,(2000)
David Mankoff, Jeanne M. Link, Michael M. Graham, Susan M. Kozawa, Minna Zheng, Anthony F. Shields, Kenneth A. Krohn, Analysis of 2-carbon-11-thymidine blood metabolites in PET imaging. The Journal of Nuclear Medicine. ,vol. 37, pp. 290- 296 ,(1996)
Albert J H Suurmeijer, Harald J Hoekstra, David C P Cobben, Bram Maas, Pieter L Jager, Philip H Elsinga, Bernard F A M van der Laan, Willem Vaalburg, 18F-FLT PET for Visualization of Laryngeal Cancer: Comparison with 18F-FDG PET The Journal of Nuclear Medicine. ,vol. 45, pp. 226- 231 ,(2004)
Zdenka Grunbaum, George D. Harp, George E. Sale, Janet S. Rasey, Michael M. Graham, Steven M. Larson, David L. Williams, Paul L. Weiden, Henry G. Kaplan, Positron imaging feasibility studies. I: Characteristics of [3H]thymidine uptake in rodent and canine neoplasms: concise communication. The Journal of Nuclear Medicine. ,vol. 22, pp. 869- 874 ,(1981)
Janet F. Eary, Barbara Lewellen, John R. Grierson, Michael M. Graham, David A. Mankoff, Jeanne M. Link, Thomas K. Lewellen, Kenneth A. Krohn, Susie M. Kozawa, Minna Zheng, Anthony F. Shields, Carbon-11-Thymidine and FDG to Measure Therapy Response The Journal of Nuclear Medicine. ,vol. 39, pp. 1757- 1762 ,(1998)
Kenneth A. Krohn, David A. Mankoff, Hubert Vesselle, John R. Grierson, Joanne M. Wells, Mark Muzi, Kinetic modeling of 3'-deoxy-3'-fluorothymidine in somatic tumors: mathematical studies. The Journal of Nuclear Medicine. ,vol. 46, pp. 371- 380 ,(2005)
Mark Muzi, Kenneth A. Krohn, David A. Mankoff, Lanell M. Peterson, Hubert Vesselle, John Grierson, 18F-Fluorothymidine radiation dosimetry in human PET imaging studies. The Journal of Nuclear Medicine. ,vol. 44, pp. 1482- 1488 ,(2003)
Laura B. Kozell, Alexander M. Spence, Kenneth A. Krohn, Jeanne M. Link, Anthony F. Shields, Susan M. Kozawa, Erik R. Swenson, James B. Bassingthwaighte, Michael M. Graham, Contribution of labeled carbon dioxide to PET imaging of carbon-11-labeled compounds. The Journal of Nuclear Medicine. ,vol. 33, pp. 581- 584 ,(1992)
Bengt Långström, Kengo Sato, Mats Bergström, Karl-Johan Fasth, Linda Samuelsson, Li Lu, Rat Studies Comparing 11C-FMAU, 18F-FLT, and 76Br-BFU as Proliferation Markers The Journal of Nuclear Medicine. ,vol. 43, pp. 1688- 1698 ,(2002)
Albert J H Suurmeijer, Harald J Hoekstra, David C P Cobben, Bram Maas, Philip H Elsinga, Piet L Jager, 3′-18F-Fluoro-3′-Deoxy-l-Thymidine: A New Tracer for Staging Metastatic Melanoma? The Journal of Nuclear Medicine. ,vol. 44, pp. 1927- 1932 ,(2003)